New drug hope for TSC seizures tested in extension study
Disease control
Terminated
This study tested the safety and effectiveness of ganaxolone, an add-on treatment, for children and adults with tuberous sclerosis complex (TSC) who have seizures. Participants had already completed a prior ganaxolone study. The main goal was to track side effects and changes in …
Phase: PHASE3 • Sponsor: Marinus Pharmaceuticals • Aim: Disease control
Last updated May 12, 2026 13:43 UTC